Report updated Apr 17, 2026

Overview · Full Intel report in progress

EndeavorOTC®: Outplay ADHD is an established medical app that is available. With a 3.9/5 rating from 2K reviews, it shows polarized user reception.

What is EndeavorOTC®: Outplay ADHD?

EndeavorOTC is a game-based digital therapeutic designed to improve attention and focus in adults with ADHD. It utilizes the same technology as the FDA-authorized EndeavorRx to provide a clinical treatment experience without requiring a prescription. The app includes a personalized progress tracking metric called the Focus Score.

Current Momentum

v4.0 · 1mo ago

Active

Last updated 50d ago. 5 versions tracked.

AI-powered deep analysis surfacing high-signal insights. Still in beta, accuracy improves daily. For informational purposes only.

Competition

Rivals identification in progress

7-Day Rank Pulse 🇺🇸

Medical

No ranking data

Rating Pulse 🇺🇸

What makes this app unique?

What Does It Look Like?

How Is The App's Momentum Right Now?

Loading...

What Are The Key Features?

Game-based TreatmentStandard

Uses technology derived from FDA-authorized software to target ADHD symptoms through gameplay.

Focus ScoreStandard

A personalized metric that allows users to track their attention progress over time.

Clinical FoundationStandard

Developed based on clinical studies involving over 220 participants over a 6-week period.

How much does it cost?

Subscription

Who Built It?

Akili Interactive Labs

(1.4K)

Providing FDA-authorized and clinically-designed game-based digital therapeutics to improve attention and focus for individuals with ADHD.

Portfolio

5

Apps

Free 4
Medical100%

Who is Akili Interactive Labs?

Akili Interactive has established a unique moat by bridging the gap between consumer gaming and regulated medical devices, securing the first-ever FDA authorization for a prescription video game. Their strategy leverages a dual-track distribution model: a prescription-based clinical path for pediatric patients and a direct-to-consumer subscription model for adults. This regulatory-first approach creates a significant barrier to entry for traditional app developers while positioning them as a leader in the emerging digital therapeutics (DTx) category.

Who is Akili Interactive Labs for?

  • Adults with ADHD
  • Parents/caregivers of children (8-17) seeking non-pharmacological
  • Clinically-validated cognitive treatments
Steady

Portfolio momentum

Maintained 3 active apps with 2 updates in the last 6 months, focusing development on their flagship adult and pediatric treatments.

Last release · 57d agoActive apps · 3Abandoned · 2

Analysis in progress, available soon

What do users think recently?

Analysis in progress, available soon

Analysis in progress, available soon

What is the competitive landscape for EndeavorOTC®: Outplay ADHD?

How's The Medical Market?

How does it evolve in the Medical market?

ChartRankChange
Grossing#549

Strategic analysis coming soon

SWOT, key takeaways & outlook

The outtake for EndeavorOTC®: Outplay ADHD

Key Takeaways

EndeavorOTC positions itself as a clinical, game-based ADHD intervention for adults, though user feedback highlights concerns regarding the subscription-only model and technical performance.

Where Is It Heading?

Trend analysis

Available very soon

Disclosure

Independent intel to help builders create better apps.

AI-powered analysis with editorial review, built from publicly available sources. See methodology.

Marlvel.ai is not affiliated with, endorsed by, or sponsored by EndeavorOTC®: Outplay ADHD, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

Hope this helps & keep building! · Found an error?

What's new in this report

No changes detected yet.

Cite this report

Marlvel.ai. “EndeavorOTC®: Outplay ADHD Intelligence Report.” Updated Apr 17, 2026. https://marlvel.ai/intel-report/medical/com-akiliinteractive-t01a

Agent Markdown (.md)·

Data licensed under CC-BY-NC 4.0